Abstract
Osteocalcin (OCN), a bone-derived hormone, is traditionally considered an indicator of bone turnover. Beyond its canonical role in bone metabolism, OCN regulates glucose and lipid metabolism, cognitive function, and sexual function. Recently, OCN has emerged as a key modulator of the acute stress response (ASR), essential for vertebrate survival. This review synthesizes current research on the OCN-stress axis, analyzing the molecular mechanisms by which bone-derived signals integrate into stress regulatory networks. Understanding OCN’s role in ASR may guide novel strategies for treating stress-related disorders such as anxiety, depression, and stress-aggravated cardiac events.
Introduction: Bone as an Endocrine Organ
Traditionally, the skeleton was viewed as a passive structural scaffold. While the Hypothalamic-Pituitary-Adrenal (HPA) axis has long been recognized as the primary controller of the "fight-or-flight" response, the role of bone in this circuit was largely overlooked. Recent evidence published in Frontiers in Pharmacology establishes bone as a critical endocrine regulator. Specifically, Osteocalcin (OCN) functions as a fast-acting hormone that surges during stress to prime the body for action, acting as a vital link between the skeletal system and the central nervous system's survival mechanisms.
The OCN-Stress Axis Mechanism
When the brain perceives a threat, the amygdala sends glutamatergic signals to bone cells (osteoblasts). This inhibits the carboxylation of OCN, causing a rapid release of bioactive, uncarboxylated OCN into the bloodstream. This process occurs within minutes, often preceding or occurring concurrently with the rise in cortisol.
OCN acts as a "molecular switch" for the Autonomic Nervous System by binding to receptors on parasympathetic neurons to inhibit acetylcholine release. By silencing "rest-and-digest" signals, OCN allows the sympathetic "fight-or-flight" system to dominate without interference.
Acute vs. Chronic Stress Dynamics
The physiological impact of OCN differs significantly between acute and chronic stress states. In acute scenarios, OCN levels spike rapidly—demonstrated in mouse models to occur within 2.5 minutes of exposure to a threat. This surge promotes the adrenal response and facilitates the immediate survival reaction. However, prolonged exposure to stress leads to a depletion of OCN, which impairs the negative feedback loop of the HPA axis, potentially contributing to the chronic cortisol elevation observed in clinical depression.
Adrenal Synergy and Lifelong Homeostasis
OCN does not merely work alongside the HPA axis; it is fundamental to the development and function of the adrenal glands. Research indicates that OCN is necessary for the normal expression of Steroidogenic Factor 1 (Sf1) in fetal adrenal cells and the differentiation of adrenal cells into steroid synthesis cells. This hormonal influence begins during embryogenesis and continues postnatally, regulating the synthesis of steroids like aldosterone and corticosterone to maintain lifelong adrenal homeostasis.
Clinical Evidence and Results
The synthesis of existing literature, including animal models and human clinical data, reveals several key findings:
- Speed of Action: OCN spikes by 50–150% within minutes of stress in mice (Berger et al., 2019).
- Behavioral Impact: OCN-knockout models exhibit higher baseline anxiety and blunted physiological stress responses compared to wild-type controls.
- Human Correlation: In psychosocial stress tests, bioactive OCN levels correlate positively with increases in heart rate and blood pressure.
- Cardiac Link: Patients with acute myocardial infarction often show decreased OCN levels, suggesting that a failure in the OCN-stress axis may exacerbate cardiac events.
Limitations and Future Directions
While the OCN-stress axis presents a compelling new perspective on stress physiology, several gaps remain. Most human data is currently correlational, making it difficult to establish definitive causality. Furthermore, evidence suggests age-related "bone endocrine resistance," where older adults do not exhibit the same OCN surge during exercise as younger populations. Future research must also address sex differences in this axis and explore the therapeutic potential of OCN analogs for treating PTSD or anxiety.
This article is a summary of research published in Frontiers in Pharmacology.
Summary updated